Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John L. Higgins currently holds 2,929,148 shares of LIGAND PHARMACEUTICALS INC (LGND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John L. Higgins has been a net seller of LGND stock. They have purchased $1.1M and sold $68.7M worth of shares.
John L. Higgins's most recent insider trade was on Nov 7, 2025, when they purchased 41,038 shares at $1.38 per share.
John L. Higgins serves as Executive at LIGAND PHARMACEUTICALS INC (LGND). They have executed 235 insider transactions totaling $69.8M over their tenure at the company.
John L. Higgins holds the position of Executive at LIGAND PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 23 years and currently hold a stake valued at $0.
John L. Higgins has shown a selling trading pattern, with $1.1M in total purchases and $68.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John L. Higgins was on Nov 17, 2022, when they sold $783.2K worth of LGND shares. This transaction involved 10,000 shares at $78.32 per share.
John L. Higgins currently owns 2,929,148 shares of LIGAND PHARMACEUTICALS INC (LGND), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John L. Higgins's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John L. Higgins has 235 Form 4 filings on record as an insider at LIGAND PHARMACEUTICALS INC.
Set alerts for John L. Higgins and 40,000+ other insiders.